Beta Bionics, Inc.
BBNXNasdaqCIK 1674632HealthcareFiscal year ends Dec 31
Reports and events: 31 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:20 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001674632-26-000003 |
| 2026-10-2716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006856 |
| 2026-09-1718:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-393322 |
| 2026-09-1516:58 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-392088 |
| 2026-07-2916:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-323777 |
| 2026-07-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005010 |
| 2026-05-2216:05 ET | 8-K | 5.07 Shareholder vote results | 0001171843-26-003648 |
| 2026-05-2116:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-003617 |
| 2026-04-2116:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-166843 |
| 2026-04-2116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002614 |
| 2026-04-1016:05 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001193125-26-151235 |
| 2026-02-2416:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-067065 |
| 2026-02-1716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000859 |
| 2026-01-3016:30 ET | 8-K | 8.01 Other events | 0001171843-26-000538 |
| 2026-01-0816:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000145 |
| 2025-10-2816:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-253538 |
| 2025-10-2816:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006720 |
| 2025-07-2916:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-099652 |
| 2025-07-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004780 |
| 2025-06-2307:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004016 |
| 2025-05-0616:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064504 |
| 2025-05-0616:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002817 |
| 2025-03-2816:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-046762 |
| 2025-03-2716:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-001785 |
| 2025-03-2517:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-044516 |
| 2025-03-2516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001690 |
| 2025-01-3117:10 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-018471 |
| 2025-01-2809:11 ET | S-1/A | Registration statement, amended | 0001193125-25-013987 |
| 2025-01-2317:06 ET | S-1/A | Registration statement, amended | 0001193125-25-011507 |
| 2025-01-2206:10 ET | S-1/A | Registration statement, amended | 0001193125-25-009915 |
| 2025-01-0616:25 ET | S-1 | Registration statement | 0001193125-25-002177 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:23 ET. Listed shows no prices and gives no investment advice.